ENTEROMEND (90 VEG CAPS) (HEALTH CONCERNS)

Description

Description:

Therapeutic Actions

1.Treats symptoms of food intolerance including cramping, bloating, intestinal gas, nausea, heartburn, GERD and diarrhea

2.Reduces intestinal inflammation via anti TNF activity

3.Helps heal the intestines by breaking down foreign proteins

4.Supports the digestion a full spectrum of enzymes designed to breakdown carbohydrates, protein, and fats.

5.May be used in the treatment of gluten intolerance

Formula

Gluten intolerance is a broad term that includes all kinds of sensitivity to gluten. The general symptoms of gluten intolerance include abdominal pain, gas, and diarrhea. A more advanced type of gluten intolerance, Celiac disease is an inherited autoimmune disorder characterized by malabsorption of gluten and subsequent intestinal damage. Celiac disease is associated with digestive disorders, iron deficiency anemia, osteoporosis, intestinal cancer, lymphoma, and other autoimmune disorders such as Rheumatoid Arthritis. The accepted treatment is a strict adherence to a gluten free diet.

Within the intestinal wall are several enzymes, called Brush Border Enzymes, which are important for normal gluten breakdown. It has been theorized that if sufficient quantities of these enzymes were supplemented, gluten sensitivity could be minimized or avoided. This is important, as gluten intolerance has been noticed in patients with digestive disorders, autoimmune disease, migraine headaches, and possibly autistic spectrum disorders.

One of the enzyme activities required to break down these peptides has been identified as dipeptidyl peptidase IV (DPP IV). The lack of this enzyme activity in the small intestine due to the above conditions prevents the digestion of these peptide fragments. These peptide fragments, if left undigested, are thought to elicit immune responses that can inflame the lining of the small intestine.

The proteases in Enteromend are designed to provide standardized DPP IV activity, and are stable in the acidic environment of the stomach. Experimental research reveals the proteases contained in the formula also reduce tumor necrosis factor (TNF-a), and thefore Enteromend has anti TNF effects. Currently anti TNF strategies are used to treat inflammatory disorders such as Inflammatory Bowel Disease.

Enteromend also contains enzymes that have DPP IV activity and special enzymes to assist in the breakdown of carbohydrates, protein and fats. It contains acid maltase to assist in starch digestion, alpha galactosidase and invertase to break down sugars resulting from the fermentation of grains, legumes, and cruciferous vegetables, lactase to digest milk proteins, and special proteases to reduce inflammation and breakdown proteins.

Patent Formula Name

Enteromend

Alternative Name

Dipeptidyl Peptidase DPP-IV Enzyme Supplement

Product Line

Health Concerns

Dosage Forms

Capsules

Unit Size

60 capsules

Dosage

1-3 capsules per day

Allergy Warning

Treatment Principle

Contraindication

Indications

Treats symptoms of food intolerance including cramping, bloating, intestinal gas, nausea, heartburn, GERD and diarrhea